Floatz logo

cd22 car-transduced t cells

B-Cell Adult Acute Lymphocytic Leukemia

Zhejiang UniversityCell therapyPhase 2Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
89/ 100

Competitive context

24 Active assets in the B-Cell Adult Acute Lymphocytic Leukemia cohort.

Asset / SponsorPhaseRating
VINCRISTINE SULFATE
SWOG Cancer Research Network
Phase 3BBB
PEGASPARGASE
National Cancer Institute (NCI)
Phase 3BBB
Cyclophosphamide
The First Affiliated Hospital of Soochow University
Phase 3BBB
Cytosin-Arabinosid
Massachusetts General Hospital
Phase 3BBB
METHOTREXATE
Massachusetts General Hospital
Phase 3BBB

View all 50 →

Same molecule, other indications

cd22 car-transduced t cells is also rated in:

B-cell acute lymphoblastic leukemiaDormant
BB
Indicative ·
68 / 100
View asset →
Lymphoma, B-CellDormant
B
Indicative ·
63 / 100
View asset →
B-cell acute lymphoblastic leukemiaDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →